New Therapy for Eosinophilic Granulomatosis with Polyangiitis May be Coming to Europe

The EMA has recently published their recommendation for extending the indication of a treatment called Nucala to include patients diagnosed with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (EGPA). Specifically,…

Continue Reading New Therapy for Eosinophilic Granulomatosis with Polyangiitis May be Coming to Europe
Nucala Recommended for Three New Indications
stevepb / Pixabay

Nucala Recommended for Three New Indications

Nucala has already been approved in Europe as an add-on treatment for patients with extreme eosinophilic asthma. Now, the EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended…

Continue Reading Nucala Recommended for Three New Indications
A Combination of Nucala and Corticosteroids Was Shown to Increase Remission in EGPA
qimono / Pixabay

A Combination of Nucala and Corticosteroids Was Shown to Increase Remission in EGPA

Corticosteroids are used to treat a wide variety of inflammatory conditions, with asthma and arthritis acting as examples. However, these drugs can result in a variety of side effects, such…

Continue Reading A Combination of Nucala and Corticosteroids Was Shown to Increase Remission in EGPA

Study of the Week: Nucala’s Effectiveness in EGPA Confirmed in Real-World Study

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Nucala’s Effectiveness in EGPA Confirmed in Real-World Study